APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemoderivative

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hemoderivative Industry Growth and Trends Forecast to 2032

23 December 2025104 pages

Choose your research edition.

Industry ResearchHemoderivative Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoderivative Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Hemoderivative Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoderivative Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoderivative Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hemoderivative market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hemoderivative is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hemoderivative is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hemoderivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hemoderivative include CSL, Grifols, Kedrion, LFB Group, Octapharma, CBPO, Boya Bio, Hualan Bio and Shanghai RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hemoderivative market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemoderivative market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemoderivative market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemoderivative.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemoderivative market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemoderivative Market by Company

CSL

Grifols

Kedrion

LFB Group

Octapharma

CBPO

Boya Bio

Hualan Bio

Shanghai RAAS

Shuanglin Bio

Tiantan Bio

Weiguang Bio

Takeda

Yuanda Shuyang

Hemoderivative Segment by Type

Coagulation Factors

Immunoglobulins

Albumin

Others

Hemoderivative Segment by Application

Therapeutics

Excipient

Other

Hemoderivative Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoderivative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoderivative and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoderivative.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemoderivative manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemoderivative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coagulation Factors Table 2. Major Company of Immunoglobulins Table 3. Major Company of Albumin Table 4. Major Company of Others Table 5. Global Hemoderivative Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Hemoderivative Sales by Type (2021-2026) & (t) Table 7. Global Hemoderivative Sales Market Share in Volume by Type (2021-2026) Table 8. Global Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 9. Global Hemoderivative Sales Market Share in Value by Type (2021-2026) Table 10. Global Hemoderivative Price by Type (2021-2026) & (USD/kg) Table 11. Global Hemoderivative Sales by Type (2027-2032) & (t) Table 12. Global Hemoderivative Sales Market Share in Volume by Type (2027-2032) Table 13. Global Hemoderivative Sales by Type (2027-2032) & (US$ Million) Table 14. Global Hemoderivative Sales Market Share in Value by Type (2027-2032) Table 15. Global Hemoderivative Price by Type (2027-2032) & (USD/kg) Table 16. North America Hemoderivative Sales by Type (2021-2026) & (t) Table 17. North America Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Hemoderivative Sales by Type (2021-2026) & (t) Table 19. Europe Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Hemoderivative Sales by Type (2021-2026) & (t) Table 21. Asia-Pacific Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Hemoderivative Sales by Type (2021-2026) & (t) Table 23. Latin America Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Hemoderivative Sales by Type (2021-2026) & (t) Table 25. Middle East and Africa Hemoderivative Sales by Type (2021-2026) & (US$ Million) Table 26. Hemoderivative Industry Trends Table 27. Hemoderivative Industry Drivers Table 28. Hemoderivative Industry Opportunities and Challenges Table 29. Hemoderivative Industry Restraints Table 30. Global Hemoderivative Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Hemoderivative Revenue Market Share by Company (2021-2026) Table 32. Global Hemoderivative Sales by Company (2021-2026) & (t) Table 33. Global Hemoderivative Sales Share by Company (2021-2026) Table 34. Global Hemoderivative Market Price by Company (2021-2026) & (USD/kg) Table 35. Global Hemoderivative Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Hemoderivative Major Company Production Sites and Headquarters Table 37. Global Hemoderivative Company, Product Type & Application Table 38. Global Hemoderivative Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Hemoderivative by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Hemoderivative Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Hemoderivative Sales by Region (2021-2026) & (t) Table 43. Global Hemoderivative Sales Market Share in Volume by Region (2021-2026) Table 44. Global Hemoderivative Sales by Region (2021-2026) & (US$ Million) Table 45. Global Hemoderivative Sales Market Share in Value by Region (2021-2026) Table 46. Global Hemoderivative Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 47. Global Hemoderivative Sales by Region (2027-2032) & (t) Table 48. Global Hemoderivative Sales Market Share in Volume by Region (2027-2032) Table 49. Global Hemoderivative Sales by Region (2027-2032) & (US$ Million) Table 50. Global Hemoderivative Sales Market Share in Value by Region (2027-2032) Table 51. Global Hemoderivative Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 52. Global Hemoderivative Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Hemoderivative Sales by Application (2021-2026) & (t) Table 54. Global Hemoderivative Sales Market Share in Volume by Application (2021-2026) Table 55. Global Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 56. Global Hemoderivative Sales Market Share in Value by Application (2021-2026) Table 57. Global Hemoderivative Price by Application (2021-2026) & (USD/kg) Table 58. Global Hemoderivative Sales by Application (2027-2032) & (t) Table 59. Global Hemoderivative Sales Market Share in Volume by Application (2027-2032) Table 60. Global Hemoderivative Sales by Application (2027-2032) & (US$ Million) Table 61. Global Hemoderivative Sales Market Share in Value by Application (2027-2032) Table 62. Global Hemoderivative Price by Application (2027-2032) & (USD/kg) Table 63. North America Hemoderivative Sales by Application (2021-2026) & (t) Table 64. North America Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Hemoderivative Sales by Application (2021-2026) & (t) Table 66. Europe Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Hemoderivative Sales by Application (2021-2026) & (t) Table 68. Asia-Pacific Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Hemoderivative Sales by Application (2021-2026) & (t) Table 70. Latin America Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Hemoderivative Sales by Application (2021-2026) & (t) Table 72. Middle East and Africa Hemoderivative Sales by Application (2021-2026) & (US$ Million) Table 73. CSL Company Information Table 74. CSL Business Overview Table 75. CSL Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. CSL Hemoderivative Product Portfolio Table 77. CSL Recent Development Table 78. Grifols Company Information Table 79. Grifols Business Overview Table 80. Grifols Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. Grifols Hemoderivative Product Portfolio Table 82. Grifols Recent Development Table 83. Kedrion Company Information Table 84. Kedrion Business Overview Table 85. Kedrion Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Kedrion Hemoderivative Product Portfolio Table 87. Kedrion Recent Development Table 88. LFB Group Company Information Table 89. LFB Group Business Overview Table 90. LFB Group Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. LFB Group Hemoderivative Product Portfolio Table 92. LFB Group Recent Development Table 93. Octapharma Company Information Table 94. Octapharma Business Overview Table 95. Octapharma Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. Octapharma Hemoderivative Product Portfolio Table 97. Octapharma Recent Development Table 98. CBPO Company Information Table 99. CBPO Business Overview Table 100. CBPO Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. CBPO Hemoderivative Product Portfolio Table 102. CBPO Recent Development Table 103. Boya Bio Company Information Table 104. Boya Bio Business Overview Table 105. Boya Bio Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Boya Bio Hemoderivative Product Portfolio Table 107. Boya Bio Recent Development Table 108. Hualan Bio Company Information Table 109. Hualan Bio Business Overview Table 110. Hualan Bio Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. Hualan Bio Hemoderivative Product Portfolio Table 112. Hualan Bio Recent Development Table 113. Shanghai RAAS Company Information Table 114. Shanghai RAAS Business Overview Table 115. Shanghai RAAS Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. Shanghai RAAS Hemoderivative Product Portfolio Table 117. Shanghai RAAS Recent Development Table 118. Shuanglin Bio Company Information Table 119. Shuanglin Bio Business Overview Table 120. Shuanglin Bio Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. Shuanglin Bio Hemoderivative Product Portfolio Table 122. Shuanglin Bio Recent Development Table 123. Tiantan Bio Company Information Table 124. Tiantan Bio Business Overview Table 125. Tiantan Bio Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. Tiantan Bio Hemoderivative Product Portfolio Table 127. Tiantan Bio Recent Development Table 128. Weiguang Bio Company Information Table 129. Weiguang Bio Business Overview Table 130. Weiguang Bio Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 131. Weiguang Bio Hemoderivative Product Portfolio Table 132. Weiguang Bio Recent Development Table 133. Takeda Company Information Table 134. Takeda Business Overview Table 135. Takeda Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 136. Takeda Hemoderivative Product Portfolio Table 137. Takeda Recent Development Table 138. Yuanda Shuyang Company Information Table 139. Yuanda Shuyang Business Overview Table 140. Yuanda Shuyang Hemoderivative Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 141. Yuanda Shuyang Hemoderivative Product Portfolio Table 142. Yuanda Shuyang Recent Development Table 143. North America Hemoderivative Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 144. North America Hemoderivative Sales by Country (2021-2026) & (t) Table 145. North America Hemoderivative Sales Market Share by Country (2021-2026) Table 146. North America Hemoderivative Sales Forecast by Country (2027-2032) & (t) Table 147. North America Hemoderivative Sales Market Share Forecast by Country (2027-2032) Table 148. North America Hemoderivative Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Hemoderivative Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Hemoderivative Market Share by Country (2021-2026) Table 151. North America Hemoderivative Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Hemoderivative Market Share Forecast by Country (2027-2032) Table 153. Europe Hemoderivative Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 154. Europe Hemoderivative Sales by Country (2021-2026) & (t) Table 155. Europe Hemoderivative Sales Market Share by Country (2021-2026) Table 156. Europe Hemoderivative Sales Forecast by Country (2027-2032) & (t) Table 157. Europe Hemoderivative Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Hemoderivative Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Hemoderivative Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Hemoderivative Market Share by Country (2021-2026) Table 161. Europe Hemoderivative Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Hemoderivative Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Hemoderivative Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Hemoderivative Sales by Country (2021-2026) & (t) Table 165. Asia-Pacific Hemoderivative Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Hemoderivative Sales Forecast by Country (2027-2032) & (t) Table 167. Asia-Pacific Hemoderivative Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Hemoderivative Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Hemoderivative Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Hemoderivative Market Share by Country (2021-2026) Table 171. Asia-Pacific Hemoderivative Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Hemoderivative Market Share Forecast by Country (2027-2032) Table 173. Latin America Hemoderivative Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 174. Latin America Hemoderivative Sales by Country (2021-2026) & (t) Table 175. Latin America Hemoderivative Sales Market Share by Country (2021-2026) Table 176. Latin America Hemoderivative Sales Forecast by Country (2027-2032) & (t) Table 177. Latin America Hemoderivative Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Hemoderivative Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Hemoderivative Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Hemoderivative Market Share by Country (2021-2026) Table 181. Latin America Hemoderivative Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Hemoderivative Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Hemoderivative Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Hemoderivative Sales by Country (2021-2026) & (t) Table 185. Middle East and Africa Hemoderivative Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Hemoderivative Sales Forecast by Country (2027-2032) & (t) Table 187. Middle East and Africa Hemoderivative Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Hemoderivative Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Hemoderivative Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Hemoderivative Market Share by Country (2021-2026) Table 191. Middle East and Africa Hemoderivative Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Hemoderivative Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Hemoderivative Distributors List Table 196. Hemoderivative Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Hemoderivative Image Figure 2. Global Hemoderivative Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoderivative Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemoderivative Sales (2021-2032) & (t) Figure 5. Coagulation Factors Image Figure 6. Global Coagulation Factors Sales YoY Growth (2021-2032) & (t) Figure 7. Immunoglobulins Image Figure 8. Global Immunoglobulins Sales YoY Growth (2021-2032) & (t) Figure 9. Albumin Image Figure 10. Global Albumin Sales YoY Growth (2021-2032) & (t) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (t) Figure 13. Global Hemoderivative Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Hemoderivative Market Share by Type 2025 VS 2032 Figure 15. North America Hemoderivative Sales Market Share in Volume by Type in 2025 Figure 16. North America Hemoderivative Sales Market Share in Value by Type in 2025 Figure 17. Europe Hemoderivative Sales Market Share in Volume by Type in 2025 Figure 18. Europe Hemoderivative Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Hemoderivative Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Hemoderivative Sales Market Share in Value by Type in 2025 Figure 21. Latin America Hemoderivative Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Hemoderivative Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Hemoderivative Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Hemoderivative Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Hemoderivative Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Therapeutics Image Figure 28. Global Therapeutics Sales YoY Growth (2021-2032) & (t) Figure 29. Excipient Image Figure 30. Global Excipient Sales YoY Growth (2021-2032) & (t) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (t) Figure 33. Global Hemoderivative Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hemoderivative Market Share by Application 2025 VS 2032 Figure 35. North America Hemoderivative Sales Market Share in Volume by Application in 2025 Figure 36. North America Hemoderivative Sales Market Share in Value by Application in 2025 Figure 37. Europe Hemoderivative Sales Market Share in Volume by Application in 2025 Figure 38. Europe Hemoderivative Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Hemoderivative Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Hemoderivative Sales Market Share in Value by Application in 2025 Figure 41. Latin America Hemoderivative Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Hemoderivative Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Hemoderivative Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Hemoderivative Sales Market Share in Value by Application in 2025 Figure 45. North America Hemoderivative Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. North America Hemoderivative Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Hemoderivative Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Hemoderivative Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemoderivative Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Europe Hemoderivative Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hemoderivative Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Hemoderivative Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemoderivative Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Asia-Pacific Hemoderivative Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hemoderivative Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Hemoderivative Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemoderivative Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Latin America Hemoderivative Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hemoderivative Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Hemoderivative Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemoderivative Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 62. Middle East and Africa Hemoderivative Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hemoderivative Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Hemoderivative Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemoderivative Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Hemoderivative Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factors
  • Immunoglobulins
  • Albumin
  • Others
Applications
  • Therapeutics
  • Excipient
  • Other
Companies covered
  • CSL
  • Grifols
  • Kedrion
  • LFB Group
  • Octapharma
  • CBPO
  • Boya Bio
  • Hualan Bio
  • Shanghai RAAS
  • Shuanglin Bio
  • Tiantan Bio
  • Weiguang Bio
  • Takeda
  • Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemoderivative Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemoderivative Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemoderivative Market by Type
  6. 1.3.1 Coagulation Factors
  7. 1.3.2 Immunoglobulins
  8. 1.3.3 Albumin
  9. 1.3.4 Others
  10. 1.4 Global Hemoderivative Market Size by Type
  11. 1.4.1 Global Hemoderivative Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Hemoderivative Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Hemoderivative Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Hemoderivative Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Hemoderivative Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Hemoderivative Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Hemoderivative Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Hemoderivative Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemoderivative Industry Trends
  2. 2.2 Hemoderivative Industry Drivers
  3. 2.3 Hemoderivative Industry Opportunities and Challenges
  4. 2.4 Hemoderivative Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemoderivative Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemoderivative Sales (2021-2026)
  3. 3.3 Global Top Players by Hemoderivative Price (2021-2026)
  4. 3.4 Global Hemoderivative Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemoderivative Major Company Production Sites & Headquarters
  6. 3.6 Global Hemoderivative Company, Product Type & Application
  7. 3.7 Global Hemoderivative Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemoderivative Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemoderivative Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemoderivative Tier 1, Tier 2, and Tier 3
4 Hemoderivative Regional Status and Outlook
  1. 4.1 Global Hemoderivative Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemoderivative Historic Market Size by Region
  3. 4.2.1 Global Hemoderivative Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemoderivative Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemoderivative Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemoderivative Forecasted Market Size by Region
  7. 4.3.1 Global Hemoderivative Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemoderivative Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemoderivative Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemoderivative by Application
  1. 5.1 Hemoderivative Market by Application
  2. 5.1.1 Therapeutics
  3. 5.1.2 Excipient
  4. 5.1.3 Other
  5. 5.2 Global Hemoderivative Market Size by Application
  6. 5.2.1 Global Hemoderivative Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hemoderivative Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hemoderivative Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hemoderivative Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hemoderivative Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hemoderivative Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hemoderivative Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hemoderivative Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL
  2. 6.1.1 CSL Company Information
  3. 6.1.2 CSL Business Overview
  4. 6.1.3 CSL Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Hemoderivative Product Portfolio
  6. 6.1.5 CSL Recent Developments
  7. 6.2 Grifols
  8. 6.2.1 Grifols Company Information
  9. 6.2.2 Grifols Business Overview
  10. 6.2.3 Grifols Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grifols Hemoderivative Product Portfolio
  12. 6.2.5 Grifols Recent Developments
  13. 6.3 Kedrion
  14. 6.3.1 Kedrion Company Information
  15. 6.3.2 Kedrion Business Overview
  16. 6.3.3 Kedrion Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kedrion Hemoderivative Product Portfolio
  18. 6.3.5 Kedrion Recent Developments
  19. 6.4 LFB Group
  20. 6.4.1 LFB Group Company Information
  21. 6.4.2 LFB Group Business Overview
  22. 6.4.3 LFB Group Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LFB Group Hemoderivative Product Portfolio
  24. 6.4.5 LFB Group Recent Developments
  25. 6.5 Octapharma
  26. 6.5.1 Octapharma Company Information
  27. 6.5.2 Octapharma Business Overview
  28. 6.5.3 Octapharma Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Octapharma Hemoderivative Product Portfolio
  30. 6.5.5 Octapharma Recent Developments
  31. 6.6 CBPO
  32. 6.6.1 CBPO Company Information
  33. 6.6.2 CBPO Business Overview
  34. 6.6.3 CBPO Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CBPO Hemoderivative Product Portfolio
  36. 6.6.5 CBPO Recent Developments
  37. 6.7 Boya Bio
  38. 6.7.1 Boya Bio Company Information
  39. 6.7.2 Boya Bio Business Overview
  40. 6.7.3 Boya Bio Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Boya Bio Hemoderivative Product Portfolio
  42. 6.7.5 Boya Bio Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Bio Hemoderivative Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 Shanghai RAAS
  50. 6.9.1 Shanghai RAAS Company Information
  51. 6.9.2 Shanghai RAAS Business Overview
  52. 6.9.3 Shanghai RAAS Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai RAAS Hemoderivative Product Portfolio
  54. 6.9.5 Shanghai RAAS Recent Developments
  55. 6.10 Shuanglin Bio
  56. 6.10.1 Shuanglin Bio Company Information
  57. 6.10.2 Shuanglin Bio Business Overview
  58. 6.10.3 Shuanglin Bio Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shuanglin Bio Hemoderivative Product Portfolio
  60. 6.10.5 Shuanglin Bio Recent Developments
  61. 6.11 Tiantan Bio
  62. 6.11.1 Tiantan Bio Company Information
  63. 6.11.2 Tiantan Bio Business Overview
  64. 6.11.3 Tiantan Bio Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Tiantan Bio Hemoderivative Product Portfolio
  66. 6.11.5 Tiantan Bio Recent Developments
  67. 6.12 Weiguang Bio
  68. 6.12.1 Weiguang Bio Company Information
  69. 6.12.2 Weiguang Bio Business Overview
  70. 6.12.3 Weiguang Bio Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Weiguang Bio Hemoderivative Product Portfolio
  72. 6.12.5 Weiguang Bio Recent Developments
  73. 6.13 Takeda
  74. 6.13.1 Takeda Company Information
  75. 6.13.2 Takeda Business Overview
  76. 6.13.3 Takeda Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Takeda Hemoderivative Product Portfolio
  78. 6.13.5 Takeda Recent Developments
  79. 6.14 Yuanda Shuyang
  80. 6.14.1 Yuanda Shuyang Company Information
  81. 6.14.2 Yuanda Shuyang Business Overview
  82. 6.14.3 Yuanda Shuyang Hemoderivative Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Yuanda Shuyang Hemoderivative Product Portfolio
  84. 6.14.5 Yuanda Shuyang Recent Developments
7 North America by Country
  1. 7.1 North America Hemoderivative Sales by Country
  2. 7.1.1 North America Hemoderivative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemoderivative Sales by Country (2021-2026)
  4. 7.1.3 North America Hemoderivative Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemoderivative Market Size by Country
  6. 7.2.1 North America Hemoderivative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemoderivative Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemoderivative Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemoderivative Sales by Country
  2. 8.1.1 Europe Hemoderivative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemoderivative Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemoderivative Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemoderivative Market Size by Country
  6. 8.2.1 Europe Hemoderivative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemoderivative Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemoderivative Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemoderivative Sales by Country
  2. 9.1.1 Asia-Pacific Hemoderivative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemoderivative Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemoderivative Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemoderivative Market Size by Country
  6. 9.2.1 Asia-Pacific Hemoderivative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemoderivative Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemoderivative Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemoderivative Sales by Country
  2. 10.1.1 South America Hemoderivative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemoderivative Sales by Country (2021-2026)
  4. 10.1.3 South America Hemoderivative Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemoderivative Market Size by Country
  6. 10.2.1 South America Hemoderivative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemoderivative Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemoderivative Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemoderivative Sales by Country
  2. 11.1.1 Middle East and Africa Hemoderivative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemoderivative Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemoderivative Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemoderivative Market Size by Country
  6. 11.2.1 Middle East and Africa Hemoderivative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemoderivative Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemoderivative Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemoderivative Value Chain Analysis
  2. 12.1.1 Hemoderivative Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemoderivative Production Mode & Process
  7. 12.2 Hemoderivative Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemoderivative Distributors
  10. 12.2.3 Hemoderivative Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst